Inventor
Pierre-Jean Colson
Inventor
San Francisco, CA, US
Overview
Patents· 35 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes25%
Y02PClimate change mitigation technologies in the production or processing of goods8%
C07CAcyclic or carbocyclic compounds5%
C07BGeneral methods of organic chemistry3%
Y10TTechnical subjects covered by former us classification3%
PatentTitleYear
10,844,057Process for preparing JAK inhibitors and intermediates thereof202010,426,766Crystalline forms of an 8-azabicyclo[3.2.1]octane compound20199,949,963Crystalline forms of an 8-azabicyclo[3.2.1]octane compound20189,290,491'Crystalline forms of an 8-azabicyclo[3.2.1]octane compound'20169,221,763'Process for preparing biphenyl imidazole compounds'20159,035,061'Process for preparing a biphenyl-2-ylcarbamic acid'20158,969,370'3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists'20158,969,403'Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound'20158,889,882'Process for preparing biphenyl imidazole compounds'20148,816,091'Crystalline forms of an 8-azabicyclo[3.2.1]octane compound'20148,754,223'Crystalline form of a biphenyl compound'20148,754,225'Process for preparing a biphenyl-2-ylcarbamic acid'20148,658,691'Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound'20148,541,597'Process for preparing biphenyl imidazole compounds'20138,536,335'Crystalline forms of an 8-azabicyclo[3.2.1]octane compound'20138,492,399'3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists'20138,476,299'Crystalline form of a biphenyl compound'20138,476,440'Process for preparing an intermediate to mu opioid receptor antagonists'20138,247,559'Process for preparing an intermediate to mu opioid receptor antagonists'20128,247,555'Crystalline forms of an 8-azabicyclo[3.2.1]octane compound'20128,188,294'Process for preparing biphenyl imidazole compounds'20128,134,006'Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity'20128,106,232'3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists'20128,101,766'Crystalline form of a biphenyl compound'20127,943,772'Crystalline forms of an 8-azabicyclo(3.2.1)octane compound'20117,932,402'Process for preparing an intermediate to opioid receptor antagonists'20117,687,521'Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity'20107,524,965'Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity'20097,521,558'Crystalline form of a biphenyl compound'20097,320,990'Crystalline form of a biphenyl compound'20086,794,544'Method for the preparation of tetrahydrobenzothiepines'20046,586,434'Method for the preparation of tetrahydrobenzothiepines'20036,414,180'Synthesis of chiral -amino acids'20025,986,107'Process for the preparation of a 2-oxopyrrolidine compound'19995,840,961'Asymmetric synthesis of chiral beta-amiNo acids'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2004Based in Skokie, IL, US· patent location history
2008–2014Patents assigned to THERAVANCE INC (20)· patent assignee history
2008–2019Based in San Francisco, CA, US· patent location history
2012–2016Patents assigned to COLSON PIERRE-JEAN (21)· patent assignee history
2012–2016Patents assigned to RAPTA MIROSLAV (11)· patent assignee history
2014–2015Patents assigned to THERAVANCE BIOPHARMA R & D IP LLC (5)· patent assignee history
2015–2020Patents assigned to THERAVANCE BIOPHARMA R&D IP LLC (5)· patent assignee history
2020Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| COLSON PIERRE-JEANself | 21 | 2012–2016 |
| THERAVANCE INC | 20 | 2008–2014 |
| RAPTA MIROSLAV | 11 | 2012–2016 |
| THERAVANCE BIOPHARMA R & D IP LLC | 5 | 2014–2015 |
| THERAVANCE BIOPHARMA R&D IP LLC | 5 | 2015–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 29 | 2008–2019 |
| Skokie, Illinois, US | 5 | 1998–2004 |
| South San Francisco, California, US | 1 | 2020 |